Kamau Therapeutics

San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a clinical-stage, next-generation gene correction company intended to cure serious and life-threatening diseases. Kamau Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $48.5 million at its seed round in Jun 2025, the last priced event on record. It has raised $31.8 million across 1 recorded round; the latest was a $5 million seed round in May 2025.

PMV mark · valuation
$48.5M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$31.8M
Last round
Seed Round
May 2025

Who backs Kamau Therapeutics?

3 investors
InvestorType
Draper AssociatesVenture capital
Modi VenturesVenture capital
NEVA SGRVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kamau Therapeutics investors

3 investors are on record for Kamau Therapeutics, including Draper Associates, Modi Ventures and NEVA SGR. By type, the record holds 3 venture capital firms. The seed round in May 2025 drew 6 investors.

Free account
More of Kamau Therapeutics with a free account
  • ·Watch Kamau Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Kamau Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View